Lipopheresis in the nephrotic syndrome

Slides:



Advertisements
Similar presentations
Chapter 1: Definition and classification of CKD Kidney International Supplements Volume 3, Issue 1, Pages (January 2013) DOI: /kisup
Advertisements

Ischemic heart disease after renal transplantation
RenaGel®, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone  Eduardo A. Slatopolsky, Steven K.
LDL cholesterol in CKD—to treat or not to treat?
Anemia management in chronic kidney disease
KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 Update
Volume 66, Issue 1, Pages (July 2004)
Impact of new dialysis solutions on peritonitis rates
RenaGel®, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone  Eduardo A. Slatopolsky, Steven K.
Progression of renal failure and hypertensive nephrosclerosis
Susumu Takahashi, Kazuyoshi Okada, Mitsuru Yanai  Kidney International 
Volume 58, Issue 1, Pages (July 2000)
Peripheral microvascular parameters in the nephrotic syndrome
Volume 70, Pages S21-S25 (December 2006)
Ian H. de Boer, Rajnish Mehrotra  Kidney International 
Abnormalities in lipoprotein metabolism in hemodialysis patients
Methotrexate in the urine
Comorbidity and confounding in end-stage renal disease
Volume 74, Issue 3, Pages (August 2008)
Per-Ola Attman, M.D, Petar Alaupovic, Ola Samuelsson 
Lipid redistribution in renal dysfunction
Volume 70, Issue 11, Pages (December 2006)
D. Coyne  Kidney International  Volume 69, Pages S1-S3 (May 2006)
Volume 56, Pages S122-S125 (July 1999)
The epidemiology of chronic kidney disease
Study of Heart and Renal Protection (SHARP)
Volume 73, Pages S5-S17 (April 2008)
LDL cholesterol in CKD—to treat or not to treat?
Unfavorable course of minimal change nephrotic syndrome in children with intrauterine growth retardation  Nina Zidar, Mojca Avguštin Čavić, Rajko B. Kenda,
Public health in Africa: What is new—The context, the gains, the losses, the renewed public health, and the way forward  D.A.N.C.O. Kaseje, Pamela Juma,
Volume 87, Issue 1, Pages (January 2015)
A physician's perseverance uncovers problems in a key nephrology study
The third World Kidney Day: Looking back and thinking forward
Volume 56, Pages S37-S41 (July 1999)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Microbiology and outcomes of peritonitis in North America
AGEs in foods: Do they play a role in uremia?
Lysophosphatidylcholine induces platelet-derived growth factor gene expression in a human mesangial cell line  Yoshinori Tone, Susumu Yukawa, Zac Varghese,
Volume 87, Issue 1, Pages (January 2015)
Volume 56, Pages S137-S140 (July 1999)
Volume 67, Issue 4, Pages (April 2005)
Simvastatin in nephrotic syndrome
Nephrology Crossword: Glomerulonephritis
Volume 56, Pages S235-S237 (July 1999)
Volume 71, Issue 4, Pages (February 2007)
Proteinuria screening for children
Mediterranean diets: are they practical in the Western world?
Volume 82, Issue 9, Pages (November 2012)
Clinical benefits of slowing the progression of renal failure
Organ transplantation goes to the movies
Volume 70, Pages S84-S90 (November 2006)
Atherosclerotic nephropathy
Volume 55, Pages S3-S16 (June 1999)
Volume 83, Issue 4, Pages (April 2013)
Volume 56, Pages S28-S30 (July 1999)
Effect of lipid-lowering strategies on tubular cell biology
Charles A. Herzog  Kidney International 
Volume 76, Issue 1, Pages 8-10 (July 2009)
Volume 70, Issue 3, Pages (August 2006)
Volume 70, Issue 5, Pages (September 2006)
Volume 56, Pages S171-S173 (July 1999)
The changing face of childhood nephrotic syndrome
Dana V. Rizk, David G. Warnock  Kidney International 
Ischemic heart disease after renal transplantation
The international realities of live donor kidney transplantation
The International Pediatric Peritonitis Registry: Starting to walk
Volume 55, Pages S41-S46 (June 1999)
Lipoprotein abnormalities in diabetic nephropathy
Attitudes and predictive factors for live kidney donation: A comparison of live kidney donors versus nondonors  Lynn Stothers, William A. Gourlay, Li.
Presentation transcript:

Lipopheresis in the nephrotic syndrome Carol Brunton, Zachariah Varghese, John F. Moorhead, Dr  Kidney International  Volume 56, Pages S6-S9 (July 1999) DOI: 10.1046/j.1523-1755.1999.07102.x Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 1 Prolonged reduction in low-density lipoprotein (LDL) cholesterol in the lipopheresis group by comparison with the drugs group. (A) Total cholesterol in the lipopheresis group. (B) Total cholesterol in the drugs group. Kidney International 1999 56, S6-S9DOI: (10.1046/j.1523-1755.1999.07102.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.